Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Exagen › CFO received an award of 1,511 XGN shares
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Feb 27, 2026
Reporting period Not applicable
Filed with the SEC Mar 16, 2026 CFO Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001449439-26-000005
Filed / recorded
Mar 16, 2026, 11:17 PM UTC
Added to OQRO Oct 7, 2026, 6:56 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Jeffrey G. Black
Officer title Chief Financial Officer
Table Non-derivative (Table I)
Transaction date Feb 27, 2026
Acquired / disposed Acquired (A)
Shares owned after 343,953
Footnotes from the filing The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"). Represents shares of common stock purchased through ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Around the same time Insider filing
Traded Mar 12 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 12 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 12 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jan 11, 2026 Company filing · Form 8-K · Results, Other news Reported its results, and reported other company news Feb 24, 2026 Insider · 2 people Insiders: 2 sales (~$47K) What came next Mar 3, 2026 Insider CEO sold ~$57K of XGN shares in the open market Mar 10, 2026 Company filing · Form 8-K · Results Reported its results Apr 17, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On April 17, 2026, Ana Hooker notified the Board of Directors (the “Board”) of Exagen Inc. (the “Company”) of her decision to resign as member of the Board, including all committees thereof, effective April 17, 2026 ("Effective Time").” May 11, 2026 Company filing · Form 8-K · Results Reported its results 